AI-Developed Drugs: Demystified

What is an AI-Developed Drug? Let’s Define it Properly AI-driven drug discovery has been growing at an unprecedented pace. As of 2022, the combined pipelines of 20 AI-focused biotech companies contained approximately 160 disclosed discovery programs and preclinical assets1. By 2023, 75 molecules had entered clinical trials, with 67 still in progress2. But does this mean AI is truly 'developing' drugs? While AI plays an increasing role in various stages of drug discovery, from target identification to clinical trial optimization, the term 'AI-developed' remains ambiguous. One drug, BXCL501, has reached the market through AI-assisted repurposing, but does that truly qualify...